Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Early Stage Biotech IPOs Join Late-stage Plays In Appealing to Investors

12 Jun 2013

• By Stacy Lawrence

Related Content

As Some New Listings Thrive, IPO Pipeline Burgeons

22 Apr 2013

Ambit IPO Ambles Out; Portola And Bluebird Prepare

17 May 2013

Related Companies

Epizyme, Inc.

Bluebird Bio

Agios Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

Verastem, Inc.

Clovis Oncology, Inc.

Tesaro, Inc.

Portola Pharmaceuticals, Inc.

Humanigen, Inc.

Abbott

Eisai Co., Ltd.

Roche Holding AG

Bristol Myers Squibb Company

GSK plc

Hyperion Therapeutics, Inc.

Supernus Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc.

Prosensa Holding N.V

Additional Topics

Deals Business Strategies Clinical Trials BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.